喉和喉状细胞癌中的基因突变和差异化
Gaofei Yin1, Nuan Li1, Xiaohong Chen1
1Otolaryngology head and neck surgery, Beijing Tongren Hospital, Capital Medical University, No 1. Dongjiaomin Lane,Dongcheng District, Beijing, 100730, China.
Discover oncology
|April 28, 2025
概括
对中国喉和喉状细胞癌 (SCC) 的基因组分析确定了MAP3 K4作为潜在的驱动基因. NOTCH1-MAP3 K4相互作用影响瘤分化,影响患者的生存.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症研究 癌症研究
背景情况:
- 喉和喉平细胞癌 (SCC) 是一个严重的健康问题.
- 了解基因组变异对于有针对性的治疗和改善患者治疗结果至关重要.
研究的目的:
- 调查中国患者的基因组变异模式,这些患者患有喉和喉SCC.
- 为了将这些变异与瘤分化和临床意义相关联.
主要方法:
- 用688基因小组分析了45名中国SCC患者的基因组变异.
- 评估了差异化,预后和突变状态之间的相关性.
- 为了验证发现,UALCAN数据库对564个HNSCC样本进行了分析.
主要成果:
- 在NOTCH1,TP53,FAT1和MAP3K4中,突变率高 (>30%).
- 在中国SCC患者中,MAP3 K4被确定为潜在的驱动基因 (33%的突变率).
- NOTCH1和CSMD3突变是相互排斥的;CSMD3突变与差异化的差异有关.
- NOTCH1和MAP3 K4野生型状态与差异化瘤相关.
结论:
- MAP3 K4 是中国SCC的一个潜在的新型驱动基因.
- NOTCH1-MAP3 K4相互作用可能会影响喉和喉SCC分化.
- 需要进一步的大规模研究来验证.
关键词:
MAP3 K4 K4 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 K4 MAP3 K4 K4 K4 K5 K6 K7 K8 K8 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 K9 是的 是的 是的 是的 是的 是的 是的标记1 标记1 标记不同化的差异化基因突变 基因突变头部和部状细胞癌瘤相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K
Mutations
31.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
31.6K
Loss of Tumor Suppressor Gene Functions
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.6K


